As of 2025-06-22, the EV/EBITDA ratio of Bionano Genomics Inc (BNGO) is -0.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Bionano's latest enterprise value is 10.91 mil USD. Bionano's TTM EBITDA according to its financial statements is -48.71 mil USD. Dividing these 2 quantities gives us the above Bionano EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 14.9x | 13.9x |
| Forward P/E multiples | 15.8x - 22.6x | 18.6x |
| Fair Price | (229.38) - (216.04) | (235.61) |
| Upside | -7268.0% - -6851.2% | -7462.8% |
| Date | EV/EBITDA |
| 2025-06-18 | -0.23 |
| 2025-06-17 | -0.23 |
| 2025-06-16 | -0.25 |
| 2025-06-13 | -0.26 |
| 2025-06-12 | -0.26 |
| 2025-06-11 | -0.26 |
| 2025-06-10 | -0.26 |
| 2025-06-09 | -0.26 |
| 2025-06-06 | -0.26 |
| 2025-06-05 | -0.26 |
| 2025-06-04 | -0.26 |
| 2025-06-03 | -0.26 |
| 2025-06-02 | -0.26 |
| 2025-05-30 | -0.26 |
| 2025-05-29 | -0.26 |
| 2025-05-28 | -0.26 |
| 2025-05-27 | -0.26 |
| 2025-05-23 | -0.26 |
| 2025-05-22 | -0.26 |
| 2025-05-21 | -0.25 |
| 2025-05-20 | -0.26 |
| 2025-05-19 | -0.26 |
| 2025-05-16 | -0.26 |
| 2025-05-15 | -0.27 |
| 2025-05-14 | -0.26 |
| 2025-05-13 | -0.28 |
| 2025-05-12 | -0.27 |
| 2025-05-09 | -0.27 |
| 2025-05-08 | -0.27 |
| 2025-05-07 | -0.26 |
| 2025-05-06 | -0.26 |
| 2025-05-05 | -0.28 |
| 2025-05-02 | -0.28 |
| 2025-05-01 | -0.28 |
| 2025-04-30 | -0.28 |
| 2025-04-29 | -0.29 |
| 2025-04-28 | -0.30 |
| 2025-04-25 | -0.30 |
| 2025-04-24 | -0.30 |
| 2025-04-23 | -0.29 |
| 2025-04-22 | -0.28 |
| 2025-04-21 | -0.28 |
| 2025-04-17 | -0.28 |
| 2025-04-16 | -0.28 |
| 2025-04-15 | -0.31 |
| 2025-04-14 | -0.34 |
| 2025-04-11 | -0.32 |
| 2025-04-10 | -0.31 |
| 2025-04-09 | -0.22 |
| 2025-04-08 | -0.20 |